Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for Bronchopulmonary Dysplasia in Preterms
NCT06925360Phase 2Recruiting
- Sponsor
- International Peace Maternity and Child Health Hospital
- Start
- Apr 2025
- Primary completion
- Dec 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of intravenous immunoglobulin G in bronchopulmonary dysplasia (BPD), sponsored by International Peace Maternity and Child Health Hospital. Started Apr 2025; status: recruiting.
02
Drugs
intravenous immunoglobulin G
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT06925360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06925360.